Author,Year,Experiment,Technology,Target genes,Guides per gene,Control guides,Total guides,Number of cells,Assigned cells,Assigned cells per gene,Guides per cell,Perturbation,Library targets,Cell line,groups,Effects
"Dixit et al.",2016,,Perturbseq,24,3,1,68,32 624,all,1400,1,NHEJ-KO,Transcription factors + cell cycle regulators, "BMDCs, K562",7/14 days, hardly
"Dateligner et al.",2017,,CROPseq,29,3,29,116,6958,2755,160,1,NHEJ-KO,T-cell receptor (TCR) signaling,,,hardly
"Dateligner et al.",2017,,CROPseq,29,3,29,116,8857,3 449,160,1,NHEJ-KO,transcription factors,,, hardly
"Hill et al.",2018,,CROP-seq,32,6,6,198,5879,94%,167,CRISPRi,Tumor suppressors,MCF10A, +/- doxorubicin, "yes, e.g., p53"
"Frangieh et al.",2020,,Perturbseq,248,3,74,810,218000,all,800,1,NHEJ-KO,Immunologic Constant of Rejection (ICR) signature,,,
"Gasperini et al.",2019,,  ,5920,2 to 4,50,,255 000,255 000,516,28,CRISPRi,Enhancers,,,
"Norman et al.",2019,,  ,105,1,4,287 pairs,110 000,93 000,850,2,CRISPRa,Growth interaction screen hits,,,"Yes, plenty"
"Jost et al.",2020,,  ,25,5 to 6,10,138,,19 600,730,1,CRISPRi,Essential genes,,,"Yes, plenty"
